A Phase I/Iia Study Of Lemzoparlimab, A Monoclonal Antibody Targeting Cd47, In Patients With Relapsed And/Or Refractory Acute Myeloid Leukemia (Aml) And Myelodysplastic Syndrome (Mds): Initial Phase I Results
BLOOD（2020）
Abstract
Background
MoreTranslated text
Key words
CD47
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined